[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 Top 5 Diabetes Drugs Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

June 2018 | 141 pages | ID: 21B276DFC35EN
LP Information

US$ 4,960.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life.

All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots.

As World overall economic downward trend in the past few years, and international economic situation is complicated, in the next few years there will be many uncertainties, coupled with diabetes drug industry in short supply on the market in the past few years, more companies will enter into the diabetes drug industry, the current demand for diabetes drug product is relatively high; comparing to the ordinary diabetes drug products selling on the market. Diabetes drug’s price remains in the same level as compared with the past years. The signal of market price change indicates the trend in the diabetes drug industry, the market still have large potential.

Over the next five years, LPI(LP Information) projects that Diabetes Drugs will register a 5.4% CAGR in terms of revenue, reach US$ 77900 million by 2023, from US$ 57000 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
  • Sanofi
  • Novo Nordisk
  • MSD
  • Astrazeneca
  • Takeda
  • Novartis
  • North China Pharmaceutical Group Corporation
  • Huadong Medicine
  • Dongbao Pharmaceutical Co.,LTD
  • Hisun Pharmacy
  • KELUN
  • Ginwa
  • Tianan Pharmaceutical
  • Jumpcan Pharmacy
  • Guangzhou Baiyun Mountain
  • SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD
  • Wanbang Biopharmaceuticals
  • Gan & Lee
  • Taloph
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
  • North America (United States, Canada and Mexico)
  • Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
  • Europe (Germany, UK, France, Italy and Russia etc.)
  • South America (Brazil, Chile, Peru and Argentina)
  • Middle East and Africa (Egypt, South Africa, Saudi Arabia)

    Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
    • Sulphonylureas
    • Biguanides
    • Meglitinides
    • Thiazolidinediones
    • Alpha-glucosidase Inhibitors
    • DPP-4 Inhibitors
    • SGLT-2 Inhibitors
    Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
    • Application 1
    • Application 2
  • 1 DIABETES DRUGS MARKET OVERVIEW

    1.1 Product Overview and Scope of Diabetes Drugs
    1.2 Diabetes Drugs Segment by Types
      1.2.1 Global Sales Market Share of Diabetes Drugs by Types in 2017
      1.2.2 Sulphonylureas
        1.2.2.1 Major Players of Type I
      1.2.3 Biguanides
        1.2.3.1 Major Players of Biguanides
      1.2.4 Meglitinides
        1.2.4.1 Major Players of Meglitinides
      1.2.5 Thiazolidinediones
        1.2.5.1 Major Players of Thiazolidinediones
      1.2.6 Alpha-glucosidase Inhibitors
        1.2.6.1 Major Players of Alpha-glucosidase Inhibitors
      1.2.7 DPP-4 Inhibitors
        1.2.7.1 Major Players of DPP-4 Inhibitors
      1.2.8 SGLT-2 Inhibitors
        1.2.8.1 Major Players of SGLT-2 Inhibitors
    1.3 Diabetes Drugs Segment by Applications
      1.3.1 Diabetes Drugs Sales Market Share by Applications in 2017
      1.3.2 Application
      1.3.3 Application
    1.4 Diabetes Drugs Market by Regions
      1.4.1 North America Status and Prospect (2013-2023)
        1.4.1.1 North America Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
      1.4.2 Asia-Pacific Status and Prospect (2013-2023)
        1.4.2.1 Asia-Pacific Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
      1.4.3 Europe Status and Prospect (2013-2023)
        1.4.3.1 Europe Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
      1.4.4 South America Status and Prospect (2013-2023)
        1.4.4.1 South America Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
      1.4.5 Middle East and Africa Status and Prospect (2013-2023)
        1.4.5.1 Middle East and Africa Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    1.5 Global Market Size (Value) of Diabetes Drugs (2013-2023)

    2 GLOBAL DIABETES DRUGS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

    2.1 Global Diabetes Drugs Sales and Market Share by Players in 2016 and 2017
      2.1.1 Global Diabetes Drugs Sales by Players in 2016 and 2017
      2.1.2 Global Diabetes Drugs Sales Market Share (%) by Players in 2016 and 2017
    2.2 Global Diabetes Drugs Revenue and Market Share by Players in 2016 and 2017
      2.2.1 Global Diabetes Drugs Revenue by Players in 2016 and 2017
      2.2.2 Global Diabetes Drugs Revenue Market Share (%) by Players in 2016 and 2017
    2.3 Global Diabetes Drugs Average Price by Players in 2016 and 2017
    2.4 Global Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
      2.4.1 Global Diabetes Drugs Manufacturing Base Distribution and Sales Area by Players
      2.4.2 Players Diabetes Drugs Product Types
    2.5 Diabetes Drugs Market Competitive Situation and Trends
      2.5.1 Diabetes Drugs Market Concentration Rate
      2.5.2 Diabetes Drugs Market Share of Top 3 and Top 5 Players
      2.5.3 Mergers & Acquisitions, Expansion

    3 GLOBAL DIABETES DRUGS SALES, REVENUE (VALUE) BY REGIONS, TYPE AND APPLICATION (2013-2018)

    3.1 Global Diabetes Drugs Sales, Revenue and Market Share by Regions (2013-2018)
      3.1.1 Global Diabetes Drugs Sales and Market Share by Regions (2013-2018)
      3.1.2 Global Diabetes Drugs Revenue and Market Share by Regions (2013-2018)
    3.2 Global Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      3.2.1 Global Diabetes Drugs Sales and Market Share by Type (2013-2018)
      3.2.2 Global Diabetes Drugs Revenue and Market Share by Type (2013-2018)
      3.2.3 Global Diabetes Drugs Price by Type (2013-2018)
    3.3 Global Diabetes Drugs Sales and Market Share by Application (2013-2018)
      3.3.1 Global Diabetes Drugs Sales by Application (2013-2018)
      3.3.2 Global Diabetes Drugs Sales Market Share by Application (2013-2018)
    3.4 Global Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

    4 NORTH AMERICA TOP 5 PLAYERS DIABETES DRUGS SALES, REVENUE AND PRICE

    4.1 North America Top 5 Players Diabetes Drugs Sales, Revenue and Market Share in 2016 and 2017
      4.1.1 North America Top 5 Players Diabetes Drugs Sales and Market Share in 2016 and 2017
      4.1.2 North America Top 5 Players Diabetes Drugs Revenue and Market Share in 2016 and 2017
    4.2 North America Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      4.2.1 North America Diabetes Drugs Sales and Market Share by Type (2013-2018)
        4.2.1.1 North America Diabetes Drugs Sales by Type (2013-2018)
        4.2.1.2 North America Diabetes Drugs Sales Market Share by Type (2013-2018)
      4.2.2 North America Diabetes Drugs Revenue and Market Share by Type (2013-2018)
        4.2.2.1 North America Diabetes Drugs Revenue by Type (2013-2018)
        4.2.2.2 North America Diabetes Drugs Revenue Market Share by Type (2013-2018)
      4.2.3 North America Diabetes Drugs Price by Type (2013-2018)
    4.3 North America Diabetes Drugs Sales and Market Share by Application (2013-2018)
      4.3.1 North America Diabetes Drugs Sales by Application (2013-2018)
      4.3.2 North America Diabetes Drugs Sales Market Share by Application (2013-2018)
    4.4 North America Diabetes Drugs Sales and Market Share by Country (US, Canada and Mexico) (2013-2018)
      4.4.1 North America Diabetes Drugs Sales by Country (2013-2018)
      4.4.2 North America Diabetes Drugs Sales Market Share by Country (2013-2018)
    4.5 North America Diabetes Drugs Import & Export (2013-2018)

    5 EUROPE TOP 5 PLAYERS DIABETES DRUGS SALES, REVENUE AND PRICE

    5.1 Europe Top 5 Players Diabetes Drugs Sales, Revenue and Market Share in 2016 and 2017
      5.1.1 Europe Top 5 Players Diabetes Drugs Sales and Market Share in 2016 and 2017
      5.1.2 Europe Top 5 Players Diabetes Drugs Revenue and Market Share in 2016 and 2017
    5.2 Europe Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      5.2.1 Europe Diabetes Drugs Sales and Market Share by Type (2013-2018)
        5.2.1.1 Europe Diabetes Drugs Sales by Type (2013-2018)
        5.2.1.2 Europe Diabetes Drugs Sales Market Share by Type (2013-2018)
      5.2.2 Europe Diabetes Drugs Revenue and Market Share by Type (2013-2018)
        5.2.2.1 Europe Diabetes Drugs Revenue by Type (2013-2018)
        5.2.2.2 Europe Diabetes Drugs Revenue Market Share by Type (2013-2018)
      5.2.3 Europe Diabetes Drugs Price by Type (2013-2018)
    5.3 Europe Diabetes Drugs Sales and Market Share by Application (2013-2018)
      5.3.1 Europe Diabetes Drugs Sales by Application (2013-2018)
      5.3.2 Europe Diabetes Drugs Sales Market Share by Application (2013-2018)
    5.4 Europe Diabetes Drugs Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2013-2018)
      5.4.1 Europe Diabetes Drugs Sales by Country (2013-2018)
      5.4.2 Europe Diabetes Drugs Sales Market Share by Country (2013-2018)
    5.5 Europe Diabetes Drugs Import & Export (2013-2018)

    6 ASIA-PACIFIC TOP 5 PLAYERS DIABETES DRUGS SALES, REVENUE AND PRICE

    6.1 Asia-Pacific Top 5 Players Diabetes Drugs Sales, Revenue and Market Share in 2016 and 2017
      6.1.1 Asia-Pacific Top 5 Players Diabetes Drugs Sales and Market Share in 2016 and 2017
      6.1.2 Asia-Pacific Top 5 Players Diabetes Drugs Revenue and Market Share in 2016 and 2017
    6.2 Asia-Pacific Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      6.2.1 Asia-Pacific Diabetes Drugs Sales and Market Share by Type (2013-2018)
        6.2.1.1 Asia-Pacific Diabetes Drugs Sales by Type (2013-2018)
        6.2.1.2 Asia-Pacific Diabetes Drugs Sales Market Share by Type (2013-2018)
      6.2.2 Asia-Pacific Diabetes Drugs Revenue and Market Share by Type (2013-2018)
      6.2.3 Asia-Pacific Diabetes Drugs Price by Type (2013-2018)
    6.3 Asia-Pacific Diabetes Drugs Sales and Market Share by Application (2013-2018)
      6.3.1 Asia-Pacific Diabetes Drugs Sales by Application (2013-2018)
      6.3.2 Asia-Pacific Diabetes Drugs Sales Market Share by Application (2013-2018)
    6.4 Asia-Pacific Diabetes Drugs Sales and Market Share by Country (China, Japan, Southeast Asia, India, Korea and Australia) (2013-2018)
      6.4.1 Asia-Pacific Diabetes Drugs Sales by Country (2013-2018)
      6.4.2 Asia-Pacific Diabetes Drugs Sales Market Share by Country (2013-2018)
    6.5 Asia-Pacific Diabetes Drugs Import & Export (2013-2018)

    7 SOUTH AMERICA TOP 5 PLAYERS DIABETES DRUGS SALES, REVENUE AND PRICE

    7.1 South America Top 5 Players Diabetes Drugs Sales, Revenue and Market Share in 2016 and 2017
      7.1.1 South America Top 5 Players Diabetes Drugs Sales and Market Share in 2016 and 2017
      7.1.2 South America Top 5 Players Diabetes Drugs Revenue and Market Share in 2016 and 2017
    7.2 South America Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      7.2.1 South America Diabetes Drugs Sales and Market Share by Type (2013-2018)
        7.2.1.1 South America Diabetes Drugs Sales by Type (2013-2018)
        7.2.1.2 South America Diabetes Drugs Sales Market Share by Type (2013-2018)
      7.2.2 South America Diabetes Drugs Revenue and Market Share by Type (2013-2018)
        7.2.2.1 South America Diabetes Drugs Revenue by Type (2013-2018)
        7.2.2.2 South America Diabetes Drugs Revenue and Market Share by Type (2013-2018)
      7.2.3 South America Diabetes Drugs Price by Type (2013-2018)
    7.3 South America Diabetes Drugs Sales and Market Share by Application (2013-2018)
      7.3.1 South America Diabetes Drugs Sales by Application (2013-2018)
      7.3.2 South America Diabetes Drugs Sales Market Share by Application (2013-2018)
    7.4 South America Diabetes Drugs Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2013-2018)
      7.4.1 South America Diabetes Drugs Sales by Country (2013-2018)
      7.4.2 South America Diabetes Drugs Sales Market Share by Country (2013-2018)
    7.5 South America Diabetes Drugs Import & Export (2013-2018)

    8 MIDDLE EAST & AFRICA TOP 5 PLAYERS DIABETES DRUGS SALES, REVENUE AND PRICE

    8.1 Middle East & Africa Top 5 Players Diabetes Drugs Sales, Revenue and Market Share in 2016 and 2017
      8.1.1 Middle East & Africa Top 5 Players Diabetes Drugs Sales and Market Share in 2016 and 2017
      8.1.2 Middle East & Africa Top 5 Players Diabetes Drugs Revenue and Market Share in 2016 and 2017
    8.2 Middle East & Africa Diabetes Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
      8.2.1 Middle East & Africa Diabetes Drugs Sales and Market Share by Type (2013-2018)
        8.2.1.1 Middle East & Africa Diabetes Drugs Sales by Type (2013-2018)
        8.2.1.2 Middle East & Africa Diabetes Drugs Sales Market Share by Type (2013-2018)
      8.2.2 Middle East & Africa Diabetes Drugs Revenue and Market Share by Type (2013-2018)
        8.2.2.1 Middle East & Africa Diabetes Drugs Revenue by Type (2013-2018)
        8.2.2.2 Middle East & Africa Diabetes Drugs Revenue Market Share by Type (2013-2018)
      8.2.3 Middle East & Africa Diabetes Drugs Price by Type (2013-2018)
    8.3 Middle East & Africa Diabetes Drugs Sales and Market Share by Application (2013-2018)
      8.3.1 Middle East & Africa Diabetes Drugs Sales by Application (2013-2018)
      8.3.2 Middle East & Africa Diabetes Drugs Sales Market Share by Application (2013-2018)
    8.4 Middle East & Africa Diabetes Drugs Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2013-2018)
      8.4.1 Middle East & Africa Diabetes Drugs Sales by Country (2013-2018)
      8.4.2 Middle East & Africa Diabetes Drugs Sales Market Share by Country (2013-2018)
    8.5 Middle East & Africa Diabetes Drugs Import & Export (2013-2018)

    9 GLOBAL DIABETES DRUGS PLAYERS PROFILES/ANALYSIS

    9.1 Sanofi
      9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.1.2 Diabetes Drugs Product Types, Application and Specification
        9.1.2.1 Product A
        9.1.2.2 Product B
      9.1.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.1.4 Main Business/Business Overview
      9.1.5 Sanofi News
    9.2 Novo Nordisk
      9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.2.2 Diabetes Drugs Product Types, Application and Specification
        9.2.2.1 Product A
        9.2.2.2 Product B
      9.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.2.4 Main Business/Business Overview
      9.2.5 Novo Nordisk News
    9.3 MSD
      9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.3.2 Diabetes Drugs Product Types, Application and Specification
        9.3.2.1 Product A
        9.3.2.2 Product B
      9.3.3 MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.3.4 Main Business/Business Overview
      9.3.5 MSD News
    9.4 Astrazeneca
      9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.4.2 Diabetes Drugs Product Types, Application and Specification
        9.4.2.1 Product A
        9.4.2.2 Product B
      9.4.3 Astrazeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.4.4 Main Business/Business Overview
      9.4.5 Astrazeneca News
    9.5 Takeda
      9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.5.2 Diabetes Drugs Product Types, Application and Specification
        9.5.2.1 Product A
        9.5.2.2 Product B
      9.5.3 Takeda Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.5.4 Main Business/Business Overview
      9.5.5 Takeda News
    9.6 Novartis
      9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.6.2 Diabetes Drugs Product Types, Application and Specification
        9.6.2.1 Product A
        9.6.2.2 Product B
      9.6.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.6.4 Main Business/Business Overview
      9.6.5 Novartis News
    9.7 North China Pharmaceutical Group Corporation
      9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.7.2 Diabetes Drugs Product Types, Application and Specification
        9.7.2.1 Product A
        9.7.2.2 Product B
      9.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.7.4 Main Business/Business Overview
      9.7.5 North China Pharmaceutical Group Corporation News
    9.8 Huadong Medicine
      9.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.8.2 Diabetes Drugs Product Types, Application and Specification
        9.8.2.1 Product A
        9.8.2.2 Product B
      9.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.8.4 Main Business/Business Overview
      9.8.5 Huadong Medicine News
    9.9 Dongbao Pharmaceutical Co.,LTD
      9.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.9.2 Diabetes Drugs Product Types, Application and Specification
        9.9.2.1 Product A
        9.9.2.2 Product B
      9.9.3 Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.9.4 Main Business/Business Overview
      9.9.5 Dongbao Pharmaceutical Co.,LTD News
    9.10 Hisun Pharmacy
      9.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      9.10.2 Diabetes Drugs Product Types, Application and Specification
        9.10.2.1 Product A
        9.10.2.2 Product B
      9.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
      9.10.4 Main Business/Business Overview
      9.10.5 Hisun Pharmacy News
    9.11 KELUN
    9.12 Ginwa
    9.13 Tianan Pharmaceutical
    9.14 Jumpcan Pharmacy
    9.15 Guangzhou Baiyun Mountain
    9.16 SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD
    9.17 Wanbang Biopharmaceuticals
    9.18 Gan & Lee
    9.19 Taloph

    10 GLOBAL DIABETES DRUGS MARKET FORECAST (2018-2023)

    10.1 Global Diabetes Drugs Sales, Revenue Forecast (2018-2023)
    10.2 Global Diabetes Drugs Sales, Consumption Forecast by Regions (2018-2023)
      10.2.1 Global Diabetes Drugs Sales Forecast by Regions (2018-2023)
      10.2.2 Global Diabetes Drugs Sales Market Share Forecast by Regions (2018-2023)
    10.3 Global Diabetes Drugs Sales and Market Share Forecast by Type (2018-2023)
      10.3.1 Global Diabetes Drugs Sales Forecast by Type (2018-2023)
      10.3.2 Global Diabetes Drugs Sales Market Share Forecast by Type (2018-2023)
    10.4 Global Diabetes Drugs Sales and Market Share Forecast by Application (2018-2023)
      10.4.1 Global Diabetes Drugs Sales Forecast by Application (2018-2023)
      10.4.2 Global Diabetes Drugs Sales Market Share Forecast by Application (2018-2023)
    10.5 Diabetes Drugs Price Forecast (2018-2023)

    11 DIABETES DRUGS MANUFACTURING COST ANALYSIS

    11.1 Diabetes Drugs Key Raw Materials Analysis
      11.1.1 Key Raw Materials
      11.1.2 Price Trend of Key Raw Materials
      11.1.3 Key Suppliers of Raw Materials
      11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
      11.2.1 Raw Materials
      11.2.2 Labor Cost
      11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Diabetes Drugs

    12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

    12.1 Diabetes Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Diabetes Drugs Major Players in 2017
    12.4 Downstream Buyers

    13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

    13.1 Marketing Channel
      13.1.1 Direct Marketing
      13.1.2 Indirect Marketing
      13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
      13.2.1 Pricing Strategy
      13.2.2 Brand Strategy
      13.2.3 Target Client
    13.3 Distributors/Traders List

    14 MARKET EFFECT FACTORS ANALYSIS

    14.1 Technology Progress/Risk
      14.1.1 Substitutes Threat
      14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

    15 RESEARCH FINDINGS AND CONCLUSION

    16 APPENDIX

    16.1 Methodology
    16.2 Data Source
    LIST OF TABLES AND FIGURES

    Figure Picture of Diabetes Drugs
    Table Product Specifications of Diabetes Drugs
    Figure Global Sales Market Share of Diabetes Drugs by Types in 2017
    Figure Product Picture of Sulphonylureas
    Table Major Players of Sulphonylureas
    Figure Product Picture of Biguanides
    Table Major Players of Biguanides
    Figure Product Picture of Meglitinides
    Table Major Players of Meglitinides
    Figure Product Picture of Thiazolidinediones
    Table Major Players of Thiazolidinediones
    Figure Product Picture of Alpha-glucosidase Inhibitors
    Table Major Players of Alpha-glucosidase Inhibitors
    Figure Product Picture of DPP-4 Inhibitors
    Table Major Players of DPP-4 Inhibitors
    Figure Product Picture of SGLT-2 Inhibitors
    Table Major Players of SGLT-2 Inhibitors
    Figure Diabetes Drugs Sales Market Share by Applications in 2017
    Table Applications of Diabetes Drugs
    Figure Application 1 Examples
    Figure Application 2 Examples
    Figure North America Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Figure Asia-Pacific Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Figure Europe Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Figure South America Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Figure Middle East and Africa Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Figure Global Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2023)
    Table Global Diabetes Drugs Sales by Players in 2016 and 2017
    Table Global Diabetes Drugs Sales Market Share (%) by Players in 2016 and 2017
    Figure Global Diabetes Drugs Sales Market Share by Players in 2016
    Figure Global Diabetes Drugs Sales Market Share by Players in 2017
    Table Global Diabetes Drugs Revenue by Players in 2016 and 2017
    Table Global Diabetes Drugs Revenue Market Share (%) by Players in 2016 and 2017
    Figure Global Diabetes Drugs Revenue Market Share by Players in 2016
    Figure Global Diabetes Drugs Revenue Market Share by Players in 2017
    Table Global Diabetes Drugs Average Price by Players in 2016 and 2017
    Figure Global Diabetes Drugs Average Price by Players in 2017
    Table Global Diabetes Drugs Manufacturing Base Distribution and Sales Area by Players
    Table Players Diabetes Drugs Product Types
    Figure Diabetes Drugs Market Share of Top 3 Players
    Figure Diabetes Drugs Market Share of Top 5 Players
    Table Global Diabetes Drugs Sales by Regions (2013-2018)
    Table Global Diabetes Drugs Sales Market Share by Regions (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Regions (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Regions in 2017
    Table Global Diabetes Drugs Revenue by Regions (2013-2018)
    Table Global Diabetes Drugs Revenue Market Share by Regions (2013-2018)
    Figure Global Diabetes Drugs Revenue Market Share by Regions (2013-2018)
    Figure Global Diabetes Drugs Revenue Market Share by Regions in 2017
    Table Global Diabetes Drugs Sales by Type (2013-2018)
    Table Global Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Type in 2017
    Table Global Diabetes Drugs Revenue by Type (2013-2018)
    Table Global Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Global Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Global Diabetes Drugs Revenue Market Share by Type in 2017
    Table Global Diabetes Drugs Price by Type (2013-2018)
    Table Global Diabetes Drugs Sales by Application (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Application in 2017
    Table Global Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure Global Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table Global Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Table North America Top 5 Players Diabetes Drugs Sales in 2016 and 2017
    Table North America Top 5 Players Diabetes Drugs Sales Market Share (%) in 2016 and 2017
    Figure North America Top 5 Players Diabetes Drugs Sales Share in 2016
    Figure North America Top 5 Players Diabetes Drugs Sales Share in 2017
    Table North America Top 5 Players Diabetes Drugs Revenue in 2016 and 2017
    Table North America Top 5 Players Diabetes Drugs Revenue Market Share (%) in 2016 and 2017
    Figure North America Top 5 Players Diabetes Drugs Revenue Share in 2016
    Figure North America Top 5 Players Diabetes Drugs Revenue Share in 2017
    Table North America Diabetes Drugs Sales by Type (2013-2018)
    Figure 2017 North America Diabetes Drugs Sales Market Share by Type
    Table North America Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure North America Diabetes Drugs Sales Market Share by Type (2013-2018)
    Table North America Diabetes Drugs Revenue by Type (2013-2018)
    Figure North America Diabetes Drugs Revenue Market Share by Type in 2017
    Table North America Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure North America Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Table North America Diabetes Drugs Price by Type (2013-2018)
    Table North America Diabetes Drugs Sales by Application (2013-2018)
    Figure North America Diabetes Drugs Sales by Application in 2017
    Table North America Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure North America Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table North America Diabetes Drugs Sales by Country (2013-2018)
    Figure 2017 North America Diabetes Drugs Sales Market Share by Country
    Table North America Diabetes Drugs Sales Market Share by Country (2013-2018)
    Figure North America Diabetes Drugs Sales Market Share by Country (2013-2018)
    Table North America Diabetes Drugs Import & Export (2013-2018)
    Table Europe Top 5 Players Diabetes Drugs Sales in 2016 and 2017
    Table Europe Top 5 Players Diabetes Drugs Sales Market Share (%) in 2016 and 2017
    Figure Europe Top 5 Players Diabetes Drugs Sales Share in 2016
    Figure Europe Top 5 Players Diabetes Drugs Sales Share in 2017
    Table Europe Top 5 Players Diabetes Drugs Revenue in 2016 and 2017
    Table Europe Top 5 Players Diabetes Drugs Revenue Market Share (%) in 2016 and 2017
    Figure Europe Top 5 Players Diabetes Drugs Revenue Share in 2016
    Figure Europe Top 5 Players Diabetes Drugs Revenue Share in 2017
    Table Europe Diabetes Drugs Sales by Type (2013-2018)
    Figure 2017 Europe Diabetes Drugs Sales Market Share by Type
    Table Europe Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Europe Diabetes Drugs Sales Market Share by Type (2013-2018)
    Table Europe Diabetes Drugs Revenue by Type (2013-2018)
    Figure Europe Diabetes Drugs Revenue Market Share by Type in 2017
    Table Europe Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Europe Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Table Europe Diabetes Drugs Price by Type (2013-2018)
    Table Europe Diabetes Drugs Sales by Application (2013-2018)
    Figure Europe Diabetes Drugs Sales Market Share by Application in 2017
    Table Europe Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure Europe Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table Europe Diabetes Drugs Sales by Country (2013-2018)
    Figure Europe Diabetes Drugs Sales Market Share by Country in 2017
    Table Europe Diabetes Drugs Sales Market Share by Country (2013-2018)
    Figure Europe Diabetes Drugs Sales Market Share by Country (2013-2018)
    Table Europe Diabetes Drugs Import & Export (2013-2018)
    Table Asia-Pacific Top 5 Players Diabetes Drugs Sales in 2016 and 2017
    Table Asia-Pacific Top 5 Players Diabetes Drugs Sales Market Share (%) in 2016 and 2017
    Figure Asia-Pacific Top 5 Players Diabetes Drugs Sales Share in 2016
    Figure Asia-Pacific Top 5 Players Diabetes Drugs Sales Share in 2017
    Table Asia-Pacific Top 5 Players Diabetes Drugs Revenue in 2016 and 2017
    Table Asia-Pacific Top 5 Players Diabetes Drugs Revenue Market Share (%) in 2016 and 2017
    Figure Asia-Pacific Top 5 Players Diabetes Drugs Revenue Share in 2016
    Figure Asia-Pacific Top 5 Players Diabetes Drugs Revenue Share in 2017
    Table Asia-Pacific Diabetes Drugs Sales by Type (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales Market Share by Type in 2017
    Table Asia-Pacific Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales Market Share by Type (2013-2018)
    Table Asia-Pacific Diabetes Drugs Revenue by Type (2013-2018)
    Table Asia-Pacific Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Revenue Market Share by Type in 2017
    Table Asia-Pacific Diabetes Drugs Price by Type (2013-2018)
    Table Asia-Pacific Diabetes Drugs Sales by Application (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales by Application in 2017
    Table Asia-Pacific Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table Asia-Pacific Diabetes Drugs Sales by Country (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales Market Share by Country in 2017
    Table Asia-Pacific Diabetes Drugs Sales Market Share by Country (2013-2018)
    Figure Asia-Pacific Diabetes Drugs Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Diabetes Drugs Import & Export (2013-2018)
    Table South America Top 5 Players Diabetes Drugs Sales in 2016 and 2017
    Table South America Top 5 Players Diabetes Drugs Sales Market Share (%) in 2016 and 2017
    Figure South America Top 5 Players Diabetes Drugs Sales Share in 2016
    Figure South America Top 5 Players Diabetes Drugs Sales Share in 2017
    Table South America Top 5 Players Diabetes Drugs Revenue in 2016 and 2017
    Table South America Top 5 Players Diabetes Drugs Revenue Market Share (%) in 2016 and 2017
    Figure South America Top 5 Players Diabetes Drugs Revenue Share in 2016
    Figure South America Top 5 Players Diabetes Drugs Revenue Share in 2017
    Table South America Diabetes Drugs Sales by Type (2013-2018)
    Figure South America Diabetes Drugs Sales by Type in 2017
    Table South America Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure South America Diabetes Drugs Sales Market Share by Type (2013-2018)
    Table South America Diabetes Drugs Revenue by Type (2013-2018)
    Figure South America Diabetes Drugs Revenue by Type in 2017
    Table South America Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure South America Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Table South America Diabetes Drugs Price by Type (2013-2018)
    Table South America Diabetes Drugs Sales by Application (2013-2018)
    Figure South America Diabetes Drugs Sales by Application in 2017
    Table South America Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure South America Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table South America Diabetes Drugs Sales by Country (2013-2018)
    Figure South America Diabetes Drugs Sales by Country in 2017
    Table South America Diabetes Drugs Sales Market Share by Country (2013-2018)
    Figure South America Diabetes Drugs Sales Market Share by Country (2013-2018)
    Table South America Diabetes Drugs Import & Export (2013-2018)
    Table Middle East & Africa Top 5 Players Diabetes Drugs Sales in 2016 and 2017
    Table Middle East & Africa Top 5 Players Diabetes Drugs Sales Market Share (%) in 2016 and 2017
    Figure Middle East & Africa Top 5 Players Diabetes Drugs Sales Share in 2016
    Figure Middle East & Africa Top 5 Players Diabetes Drugs Sales Share in 2017
    Table Middle East & Africa Top 5 Players Diabetes Drugs Revenue in 2016 and 2017
    Table Middle East & Africa Top 5 Players Diabetes Drugs Revenue Market Share (%) in 2016 and 2017
    Figure Middle East & Africa Top 5 Players Diabetes Drugs Revenue Share in 2016
    Figure Middle East & Africa Top 5 Players Diabetes Drugs Revenue Share in 2017
    Figure Middle East & Africa Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales by Type in 2017
    Table Middle East & Africa Diabetes Drugs Sales Market Share by Type (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales Market Share by Type (2013-2018)
    Table Middle East & Africa Diabetes Drugs Revenue by Type (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Revenue by Type in 2017
    Table Middle East & Africa Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Revenue Market Share by Type (2013-2018)
    Table Middle East & Africa Diabetes Drugs Price by Type (2013-2018)
    Table Middle East & Africa Diabetes Drugs Sales by Application (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales by Application in 2017
    Table Middle East & Africa Diabetes Drugs Sales Market Share by Application (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales Market Share by Application (2013-2018)
    Table Middle East & Africa Diabetes Drugs Sales by Country (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales by Country in 2017
    Table Middle East & Africa Diabetes Drugs Sales Market Share by Country (2013-2018)
    Figure Middle East & Africa Diabetes Drugs Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Diabetes Drugs Import & Export (2013-2018)
    Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Sanofi Diabetes Drugs Market Share (2013-2018)
    Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Novo Nordisk Diabetes Drugs Market Share (2013-2018)
    Table MSD Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure MSD Diabetes Drugs Market Share (2013-2018)
    Table Astrazeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Astrazeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Astrazeneca Diabetes Drugs Market Share (2013-2018)
    Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Takeda Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Takeda Diabetes Drugs Market Share (2013-2018)
    Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Novartis Diabetes Drugs Market Share (2013-2018)
    Table North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure North China Pharmaceutical Group Corporation Diabetes Drugs Market Share (2013-2018)
    Table Huadong Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Huadong Medicine Diabetes Drugs Market Share (2013-2018)
    Table Dongbao Pharmaceutical Co.,LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Market Share (2013-2018)
    Table Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Hisun Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
    Figure Hisun Pharmacy Diabetes Drugs Market Share (2013-2018)
    Table KELUN Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Ginwa Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Tianan Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Jumpcan Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Guangzhou Baiyun Mountain Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Wanbang Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Gan & Lee Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Taloph Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Figure Global Diabetes Drugs Sales and Growth Rate Forecast (2018-2023)
    Figure Global Diabetes Drugs Revenue and Growth Rate Forecast (2018-2023)
    Table Global Diabetes Drugs Sales Forecast by Regions (2018-2023)
    Table Global Diabetes Drugs Sales Market Share Forecast by Regions (2018-2023)
    Table Global Diabetes Drugs Sales Forecast by Type (2018-2023)
    Table Global Diabetes Drugs Sales Market Share Forecast by Type (2018-2023)
    Table Global Diabetes Drugs Sales Forecast by Application (2018-2023)
    Table Global Diabetes Drugs Sales Market Share Forecast by Application (2018-2023)
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Diabetes Drugs
    Figure Manufacturing Process Analysis of Diabetes Drugs
    Figure Diabetes Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Diabetes Drugs Major Players in 2017
    Table Major Buyers of Diabetes Drugs
    Table Distributors/Traders List


    More Publications